HCPCS Codes Similar to G9313

HCPCS Codes Similar to “G9313” Code.
Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason

G9314 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	G9315 Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis Code added date: 20140101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
S0040 Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams Code added date: 20000101 Code effective date: 20000101 TXT \| PDF \| XML \| JSON	M1411 Currently on first-line immune checkpoint inhibitors without chemotherapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1412 Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1413 Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1414 Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1415 Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
A4672 Drainage extension line, sterile, for dialysis, each Code added date: 20040101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	A4673 Extension line with easy lock connectors, used with dialysis Code added date: 20040101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
B4105 In-line cartridge containing digestive enzyme(s) for enteral feeding, each Code added date: 20190101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	G9891 Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em) hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only) Code added date: 20180401 Code effective date: 20180401 TXT \| PDF \| XML \| JSON
L2275 Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined Code added date: 19940101 Code effective date: 19960101 TXT \| PDF \| XML \| JSON	M1145 Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier) Code added date: 20210101 Code effective date: 20220228 TXT \| PDF \| XML \| JSON